ORYZON awarded 13.26 million € through the first Important Project of Common European Inte... 08/05/2025 Healthcare Rare diseases Innovative drugs Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases. Partners - Oryzon Genomics
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE ... 08/05/2025 Healthcare Access to innovation Innovative drugs Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-of-care (SoC)... Partners
I4ID 2025 Lyon Francia Del 13/11/2025 to 14/11/2025 Healthcare Innovative drugs 9th Immunotherapies and Innovations for Infectious Diseases Congress
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the ... 29/04/2025 Healthcare Innovative drugs Together, these studies reinforce the concept that advanced peptide-based brain shuttle technologies—central to the... Partners - Gate2Brain
ORYZON continues to strengthen its patent portfolio for vafidemstat 22/04/2025 Healthcare Innovative drugs Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for ADHD and autism... Partners - Oryzon Genomics
ORYZON announces first patient dosed in NCI-sponsored Phase I/II clinical trial of iadadem... 15/04/2025 Healthcare Innovative drugs Oryzon Genomics has launched a clinical trial in the U.S. to evaluate for the first time the combination of its... Partners - Oryzon Genomics
Telum Therapeutics, Complutense University of Madrid and Carlos III Health Institute disco... 03/04/2025 Healthcare Innovative drugs It was funded by Spanish Ministry of Science, Innovation and Universities (MCIN) and the European Union through the... Partners - TELUM THERAPEUTICS
SpliceBio advances SB-007 gene therapy with the first patient dosed in the ASTRA phase 1/2... 02/04/2025 Healthcare Innovative drugs It is the most common form of juvenile macular degeneration, leading to progressive central vision loss and ultimately... Partners - Parc Científic de Barcelona
LIVERtera: Revolutionizing Cancer Research with In Silico Models and Liver Tumor Organoids 13/03/2025 Healthcare Innovative drugs Advanced therapies A Biotechnological Leap in the Fight Against Liver Cancer Partners - BeCytes Biotechnologies
Biotechnology Advances in the development of key therapies for kidney diseases 13/03/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies By 2040, chronic kidney disease (CKD) is projected to become the fifth leading cause of years of life lost, emphasizing... AseBio
